Navigation Links
Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection
Date:1/21/2009

    REDWOOD SHORES, Calif., Jan. 21 /PRNewswire-FirstCall/ --

    News Facts

-- Organizations spanning the life sciences industry -- including biopharmaceutical companies, contract research organizations (CROs) and pharmaceutical manufacturers -- are increasingly turning to Oracle(R) Remote Data Capture (RDC) 4.5.3 (http://www.oracle.com/industries/life_sciences/remote-data-capture.html)to conduct trials more efficiently and effectively.

    -- Boehringer Ingelheim
http://www.boehringer-ingelheim.com/corporate/home/home.asp), Bristol-Myers
Squibb http://www.bms.com/landing/data/index.html), ICON
http://www.iconclinical.com/), LEO Pharma
http://www.leo-pharma.com/w-site/leo/docs.nsf), PPD http://www.ppdi.com/)
and Quintiles Transnational http://www.quintiles.com/) are among a rapidly
growing group of customers using Oracle RDC 4.5.3 to help increase efficiency
in clinical trials data collection, improve data quality and enhance decision
making.

-- Oracle RDC 4.5.3, the latest release of Oracle's best-in-class electronic data capture (EDC) offering, is completely Web-based -- with zero client footprint for the HTML data entry window -- which enables improved global access and performance.

-- This enables life sciences organizations to conduct global clinical studies more cost effectively using paper, electronic data capture, or hybrid methods.

-- The Oracle EDC application helps meet the needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase staff efficiency by allowing investigators to quickly locate patient visits and case report forms (CRFs).

-- Oracle RDC 4.5.3 is integrated with Oracle Clinical (http://www.oracle.com/industries/life_sciences/oracle-clinical.html), the industry's leading clinical data management system, and is an integral component of Oracle's extensive suite of clinical trial management applications.

Supporting Quotes

-- "As one of the largest users of Oracle Remote Data Capture 4.5.3, PPD is providing clients with the robustness and flexibility this system offers. We have realized greater efficiencies since implementing Oracle RDC 4.5.3, including reduced study timelines, real-time decision making and ease of use for investigator sites," said Susan Atkinson, Senior Vice President of Biostatistics and Data Management, PPD.

-- "As a global clinical research organization, we manage clinical trials for the world's top 20 pharmaceutical organizations and leading biotechnology companies. Oracle Remote Data Capture 4.5.3 helps us to accelerate the capture of subject data and offers a robust system of edit checks to ensure the data accuracy and integrity essential to effectively managing global mega trials," said Tom O'Leary, Global Head of Data Management, ICON Clinical Research.

-- "Quintiles Transnational is committed to enhancing clinical trial efficiency for its biotech and pharmaceutical clients worldwide. We looked to Oracle Remote Data Capture to help us rationalize and accelerate the clinical trial process through automated data collection, and more rapid data processing and reporting," said Nicolas Schaltenbrand, Senior Director, Global Data Management, Quintiles Transnational.

-- "Life sciences organizations increasingly require software applications that will help them automate and effectively manage the clinical phase from study setup through submission. Oracle's comprehensive suite of applications for clinical development provides an integrated system for managing large volumes of patient data, as well as sophisticated tracking, analysis and reporting capabilities. Today, hundreds of life sciences organizations are harnessing the power of Oracle's clinical solutions to accelerate insights for better health," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit.

Supporting Resources

    -- Oracle Remote Data Capture Data Sheet
http://www.oracle.com/industries/life_sciences/rdc-onsite-datasheet.pdf)

-- Oracle Remote Data Capture 4.5.3 News Release (http://www.oracle.com/corporate/press/2008_feb/remotedatacapture.html)

    -- Oracle in Health Sciences
http://www.oracle.com/industries/health_sciences/index.html)

-- Oracle Announces Creation of Health Sciences Global Business Unit (http://www.oracle.com/us/corporate/press/015803_EN?rssid=rss_ocom_pr)

About Oracle

Oracle (Nasdaq: ORCL) is the world's largest enterprise software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.

Trademarks

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO)


'/>"/>
SOURCE Oracle
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
3. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
4. Gordon, Familant Join Baker Botts as Part of Expanded Life Sciences IP Initiative
5. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
6. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
8. Aisling Capital Announces Close of US$650M Life Sciences Fund
9. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
10. Cell Biosciences Delivers Next Generation System to Stanford University
11. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... ... Today, researchers can fast-track sample collection and analysis for ... or SNPs of interest) using one, easy-to-collect saliva sample. With the addition of ... and other relevant biomarkers can be extensively studied through a non-invasive sample type. ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):